Your browser doesn't support javascript.
loading
A phase I trial of panobinostat and epirubicin in solid tumors with a dose expansion in patients with sarcoma.
Thomas, S; Aggarwal, R; Jahan, T; Ryan, C; Troung, T; Cripps, A M; Raha, P; Thurn, K T; Chen, S; Grabowsky, J A; Park, J; Hwang, J; Daud, A; Munster, P N.
Afiliação
  • Thomas S; Department of Medicine/Hematology and Oncology, University of California, San Francisco, San Francisco, USA.
  • Aggarwal R; Department of Medicine/Hematology and Oncology, University of California, San Francisco, San Francisco, USA.
  • Jahan T; Department of Medicine/Hematology and Oncology, University of California, San Francisco, San Francisco, USA.
  • Ryan C; Department of Medicine/Hematology and Oncology, University of California, San Francisco, San Francisco, USA.
  • Troung T; Department of Medicine/Hematology and Oncology, University of California, San Francisco, San Francisco, USA.
  • Cripps AM; Department of Medicine/Hematology and Oncology, University of California, San Francisco, San Francisco, USA.
  • Raha P; Department of Medicine/Hematology and Oncology, University of California, San Francisco, San Francisco, USA.
  • Thurn KT; Department of Medicine/Hematology and Oncology, University of California, San Francisco, San Francisco, USA.
  • Chen S; Department of Medicine/Hematology and Oncology, University of California, San Francisco, San Francisco, USA.
  • Grabowsky JA; Department of Medicine/Hematology and Oncology, University of California, San Francisco, San Francisco, USA.
  • Park J; Department of Medicine/Hematology and Oncology, University of California, San Francisco, San Francisco, USA.
  • Hwang J; Department of Medicine/Hematology and Oncology, University of California, San Francisco, San Francisco, USA.
  • Daud A; Department of Medicine/Hematology and Oncology, University of California, San Francisco, San Francisco, USA.
  • Munster PN; Department of Medicine/Hematology and Oncology, University of California, San Francisco, San Francisco, USA pamela.munster@ucsf.edu.
Ann Oncol ; 27(5): 947-52, 2016 05.
Article em En | MEDLINE | ID: mdl-26903311
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Sarcoma / Epirubicina / Quimioterapia Combinada / Ácidos Hidroxâmicos / Indóis Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Sarcoma / Epirubicina / Quimioterapia Combinada / Ácidos Hidroxâmicos / Indóis Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos